DIN 00522597 — PROLOPA CAP 50-12.5 12.5 MG; 50 MG
PROLOPA CAP 50-12.5 is a capsule of Benserazide / Levodopa marketed by HOFFMANN-LA ROCHE LIMITED. The full Benserazide / Levodopa monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 00522597
- Brand name
- PROLOPA CAP 50-12.5
- Active ingredient
- Benserazide / Levodopa
- Strength
- 12.5 MG; 50 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- HOFFMANN-LA ROCHE LIMITED
- Health Canada status
- MARKETED
- Drug class
- Antiparkinson agent (dopamine precursor with peripheral decarboxylase inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Benserazide / Levodopa products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 00386464 | PROLOPA CAP 100-25 | 100 MG; 25 MG | CAPSULE | HOFFMANN-LA ROCHE LIMITED | MARKETED |
| 00386472 | PROLOPA CAP 200-50 | 200 MG; 50 MG | CAPSULE | HOFFMANN-LA ROCHE LIMITED | MARKETED |